FP7Индивидуална стипендия2011–2013

SELEFLU · Synthesis and Evaluation of 18F-Labelled N-F Reagents

7РП — „Хора“ (Действия „Мария Кюри“)

Период
2011-09-12 → 2013-09-11
Финансиране от ЕС
201 050 €
Участници
1
Схема
MC-IIF

Линиите свързват координатора с партньорите.

Накратко на български

Нови методи за синтезиране на радиоактивни флуорни съединения, като например трифлуорометилирани ароматни молекули, са в центъра на работата. Те помагат за създаването на по-добри радиоактивни маркери, които се използват при клинични изследвания с ПЕТ сканер.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Synthesis and Evaluation of 18F-Labelled N-F Reagents

One of the key objectives in the Gouverneur’s group is to capitalize on our expertise in synthetic fluorine chemistry by undertaking a research program aimed at changing dramatically the landscape of 18F-radiochemistry by providing radiochemists a filled toolbox of new radiosynthetic methods for the preparation of valuable radiotracers. In this project, at first trial, this proposal was to prepare electrophilic 18F-labelled N-F reagents of high specific activity (SA) [SA is expressed as the ratio of radioactivity relative to the mass or molar amount of the compound- critical for PET] and access their value for electrophilic 18F-fluorination. The methods for a reaction of nitrenes with nucleophilic fluorinating reagents we examined were not successful to access N-F bond formation (See, midterm report). On the course of this project, we found that branched allylic CF3 products are accessible by copper-catalyzed trifluoromethylation of allylsilanes with hypervalent iodine reagent (Chem. Eur. J. 2012). In addition, the stereoselective trifluoromethylation of allysilane under photoredox catalysis also has been achieved (Org Lett, 2013). This approach could extend to the application of hydrotirfluoromethylation of unactivated olefins accessing terminal trifluoromethyl compounds (JACS 2013). Furthermore, we demonstrated new radiosynthetic methods for [18F]labeling of CF3 arenes. Given the utility of 18F isotope, [18F]labeling of functionalized trifluoromethyl arenes and heteroarenes including pharmaceutical agents is extremely sought after in clinical practice. But, despite pressing and important issues, practicable methodologies for synthesis of [18F]labeling trifluoromethyl-substituted (hetero)arenes via a late-stage [18F]trifluoromethylation have been underdeveloped. In the year 2013, we developed two different methods accessing the (hetero)aryl—CF218F; Ag(I)-mediated [18F]fluorodecarboxylation of arylCF2COOH (Org Lett 2013) and alternatively cross-coupling trifluoromethylation of (hetero)aryl iodide precursors with [18F]CF3Cu complex formed from [18F]fluoride and a reagent acting as a difluorocarbene source. We herein discuss two categories: recent advances in performing trifluoromethylation of terminal olefin as a “cold” reaction and “hot” experiments accessing synthesis of [18F]labeling trifluoromethyl-substituted (hetero)arenes. All these improvements can be used for radiosynthesis of [18F]trifluoromethylation of pharmaceutical candidates to facilitate drug development, especially for CNS diseases. Unprecedented 18F-PET tracers for clinical studies would be synthesized by using this methodology. Its operational simplicity allows for immediate use by most establishments providing they have access to basic PET chemistry infrastructure.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

The overall objective of this proposal is to capitalise on our expertise in synthetic and fluorine organic chemistry by undertaking a research programme aimed at exploring the value of 18F-labelled N-F reagents. Upon completion of the proposed research programme, we hope to provide 18F-radiochemists with a toolbox filled with novel 18F-radiosynthetic strategies. The unconventional and innovative methods that we will investigate are designed to address well recognised pending problems in 18F-radiolabelling and to offer unprecedented radiosynthetic routes to access 18F-labelled targets. The impact of the novel radiochemistry we propose to develop is far reaching to advance Positron Emission Tomography (PET). PET is a non-invasive molecular imaging technique used clinically for diagnostic purpose and drug discovery. This expanding highly interdisciplinary area of research relies on radiotracers labelled with a positron-emitting radioisotope. 18F-Labelled molecules are frequently used because of the advantageous properties of the 18F in comparison with other non-metallic radioisotopes. For rapid progress, the radiochemistry available for 18F-labelling should be sufficiently diverse for any designed 18F-radiotracers to be accessible regardless of the point of attachment of the 18F-label. To date, this is far from the reality, as current methodologies to construct 18F-labelled molecules present with limitations. The emphasis of this proposal is on the development and use of 18F-labelled N-F reagents of high specific activity for electrophilic fluorination. These reagents should allow for the production of 18F-labelled radiotracers in high radiochemical yield, purity and specific activity.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз